Astellas Pharma
ALPMY----
Q2 FY2027 Earnings
Financial report interval: 2026.06.30 - 2026.09.30
Overview: Astellas Pharma(ALPMY) the Revenue is 4.002 B (+12.87%), Beat estimate;the EBIT is 838.98 M (+18.45%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
4.00B12.87%
3.77B6.45%
+0.23B6.42%
EBITMiss expectations
0.84B18.45%
0.99B40.20%
-0.15B21.75%
Upcoming earnings report - FY2027 Q3 Earning Release
Available dateFeb 3, 2027
Estimate Revenue3.916 B
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: USD
Quarterly
EBIT
ActualEstimateUnit: USD
Quarterly
Net income
ActualEstimateUnit: USD
Quarterly
EPS
ActualEstimateUnit: USD
Quarterly